You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, October 30, 2018 - 12:00
Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Vascular Dementia;   Lewy Body Disease;   Lewy Body Dementia With Behavioral Disturbance (Disorder);   Dementia, Mixed;   Parkinson-Dementia Syndrome;   Chronic Traumatic Encephalopathy;   Huntington's Dementia;   Wernicke Korsakoff Syndrome;   Traumatic Brain Injury;   Dementia, Multi-Infarct;   Autism;   Autism Spectrum Disorder;   Autistic Behavior;   Autistic Disorder, Current or Active State
Interventions:   Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Near Infrared Light
Sponsor:   MD Stem Cells
Recruiting
Posted: Thursday, October 4, 2018 - 12:00
Condition:   Cardiomyopathy, Familial
Interventions:   Other: Electrocardiogram;   Other: physical examination;   Other: echocardiography;   Biological: blood test
Sponsor:   University Hospital, Montpellier
Recruiting
Posted: Thursday, September 6, 2018 - 12:00
Conditions:   Diabetes Mellitus, Type 2;   Cardiovascular Diseases
Interventions:   Drug: Dapagliflozin 10mg;   Drug: Saxagliptin 5mg;   Drug: Placebo Oral Tablet
Sponsor:   Sabyasachi Sen
Not yet recruiting
Posted: Tuesday, August 14, 2018 - 12:00
Conditions:   Ischemic Stroke;   Chronic Stroke;   Hemiparesis;   Arm Paralysis
Interventions:   Combination Product: CTX0E03 Drug Product and delivery device;   Drug: Placebo
Sponsor:   ReNeuron Limited
Not yet recruiting
Posted: Wednesday, July 11, 2018 - 12:00
Condition:   Stroke
Intervention:   Device: Virtual Reality Mirror Therapy
Sponsors:   Columbia University;   Realiteer Corp.
Recruiting
Posted: Thursday, June 28, 2018 - 12:00
Condition:   Dilated Cardiomyopathy
Intervention:   Biological: Bone marrow derived mononuclear cells and G-CSF
Sponsor:   Barts & The London NHS Trust
Not yet recruiting
Posted: Wednesday, June 27, 2018 - 12:00
Condition:   Stroke
Interventions:   Drug: Adipose derived Stem Cell;   Drug: placebo
Sponsors:   University Hospital, Grenoble;   European Commission H2020 program;   University Grenoble Alps;   Servicio Madrileño de Salud, Madrid, Spain;   Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic;   Andaluz Health Service;   University of Glasgow;   University of Eastern Finland;   Etablissement Français du Sang;   University of Tampere;   Histocell SL, Spain;   Medfiles CRO, Finland;   Institut National de la Santé Et de la Recherche Médicale, France;   Hospices Civils de Lyon;   Association groupe ESSEC, France;   NOVADISCOVERY SAS, France;   FINOVATIS, France;   CHU Besancon, France;   Assistance Publique - Hôpitaux de Paris;   CHU Toulouse, France;   CHU Bordeaux, France;   CHU Cote de Nacre, Caen, France;   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau;   Servicio de Salud de Castilla La Mancha, Albacete, Spain;   Servizo Galego de Saude, Santiago de Compostela, Spain;   Pirkanmaa Hospital District, Tampere, Finland;   Hospital Vall d'Hebron;   Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta;   CH Sainte-Anne, Paris, France
Recruiting
Posted: Tuesday, June 12, 2018 - 12:00
Condition:   Multiple Organ Dysfunction Syndrome
Intervention:   Biological: MSC
Sponsor:   Fujian Medical University
Recruiting
Posted: Friday, June 8, 2018 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Behavioral: Endurance training
Sponsor:   Hospital Clinic of Barcelona
Recruiting
Posted: Monday, June 4, 2018 - 12:00
Condition:   Ischemic Stroke
Interventions:   Biological: MultiStem;   Biological: Placebo
Sponsors:   Athersys, Inc;   Medpace, Inc.
Not yet recruiting

Pages